The promises and challenges of patient-derived tumor organoids in drug development and precision oncology.

Abstract In the era of precision medicine, cancer researchers and oncologists are eagerly searching for more realistic, cost effective, and timely tumor models to aid drug development and precision oncology. Tumor models that can faithfully recapitulate the histological and molecular characteristics of various human tumors will be extremely valuable […]

View Original Source at The promises and challenges of patient-derived tumor organoids in drug development and precision oncology.